Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Ther ; 25(11): 2452-2465, 2017 11 01.
Article in English | MEDLINE | ID: mdl-28807568

ABSTRACT

Anti-CD19 chimeric antigen receptor (CAR) T cells have caused remissions of B cell malignancies, but problems including cytokine-mediated toxicity and short persistence of CAR T cells in vivo might limit the effectiveness of anti-CD19 CAR T cells. Anti-CD19 CARs that have been tested clinically had single-chain variable fragments (scFvs) derived from murine antibodies. We have designed and constructed novel anti-CD19 CARs containing a scFv with fully human variable regions. T cells expressing these CARs specifically recognized CD19+ target cells and carried out functions including degranulation, cytokine release, and proliferation. We compared CARs with CD28 costimulatory moieties along with hinge and transmembrane domains from either the human CD28 molecule or the human CD8α molecule. Compared with T cells expressing CARs with CD28 hinge and transmembrane domains, T cells expressing CARs with CD8α hinge and transmembrane domains produced lower levels of cytokines and exhibited lower levels of activation-induced cell death (AICD). Importantly, CARs with hinge and transmembrane regions from either CD8α or CD28 had similar abilities to eliminate established tumors in mice. In anti-CD19 CARs with CD28 costimulatory moieties, lower levels of inflammatory cytokine production and AICD are potential clinical advantages of CD8α hinge and transmembrane domains over CD28 hinge and transmembrane domains.


Subject(s)
CD28 Antigens/immunology , CD8 Antigens/immunology , Immunotherapy, Adoptive/methods , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Receptors, Antigen, T-Cell/immunology , Single-Chain Antibodies/genetics , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Antigens, CD19/genetics , Antigens, CD19/immunology , CD28 Antigens/genetics , CD8 Antigens/genetics , Cell Line, Tumor , Gene Expression , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Lymphocyte Transfusion , Mice , Plasmids/chemistry , Plasmids/metabolism , Protein Domains , Receptors, Antigen, T-Cell/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Single-Chain Antibodies/chemistry , Survival Analysis , T-Lymphocytes/cytology , T-Lymphocytes/transplantation , Transduction, Genetic , Tumor Burden , Xenograft Model Antitumor Assays
2.
PLoS One ; 11(2): e0147254, 2016.
Article in English | MEDLINE | ID: mdl-26840340

ABSTRACT

Pancreatic amyloid formation by islet amyloid polypeptide (IAPP) is a hallmark pathological feature of type 2 diabetes. IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis. IAPP is innocuous under homeostatic conditions but imbalances in production or processing of IAPP may result in homodimer formation leading to the rapid production of cytotoxic oligomers and amyloid fibrils. The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets. Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly associated with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease. Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity. The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degradation. These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-associated hyperamylinaemia.


Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Aspartic Acid Endopeptidases/metabolism , Islet Amyloid Polypeptide/metabolism , Amino Acid Sequence , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Animals , Aspartic Acid Endopeptidases/antagonists & inhibitors , Cell Line , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/pathology , Humans , Insulin/metabolism , Insulin/pharmacology , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Islet Amyloid Polypeptide/chemistry , Islet Amyloid Polypeptide/genetics , Mass Spectrometry , Mice , Molecular Sequence Data , Mutation , Plaque, Amyloid/metabolism , Proteolysis/drug effects , Recombinant Proteins , Substrate Specificity
3.
Biochemistry ; 50(13): 2456-63, 2011 Apr 05.
Article in English | MEDLINE | ID: mdl-21323366

ABSTRACT

Prion represents a unique class of pathogens devoid of nucleic acid. The deadly diseases transmitted by it between members of one species and, in certain instances, to members of other species present a public health concern. Transmissibility and the barriers to transmission between species have been suggested to arise from the degree to which a pathological protein conformation from an individual of one species can seed a pathological conformation in another species. However, this hypothesis has never been illustrated at an atomic level. Here we present three X-ray atomic structures of the same segment from human, mouse, and hamster PrP, which is critical for forming amyloid and confers species specificity in PrP seeding experiments. The structures reveal that different sequences encode different steric zippers and suggest that the degree of dissimilarity of these zipper structures gives rise to transmission barriers in prion disease, such as those that protect humans from acquiring bovine spongiform encephalopathy (BSE) and chronic wasting disease (CWD).


Subject(s)
Prion Diseases/prevention & control , Prion Diseases/transmission , Prions/chemistry , Amino Acid Motifs , Amyloid/chemistry , Animals , Cricetinae , Crystallography, X-Ray , Humans , Mice , Peptide Fragments/chemistry , Protein Conformation , Protein Refolding , Recombinant Proteins/chemistry , Species Specificity
4.
Nat Struct Mol Biol ; 16(9): 973-8, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19684598

ABSTRACT

In prion inheritance and transmission, strains are phenotypic variants encoded by protein 'conformations'. However, it is unclear how a protein conformation can be stable enough to endure transmission between cells or organisms. Here we describe new polymorphic crystal structures of segments of prion and other amyloid proteins, which offer two structural mechanisms for the encoding of prion strains. In packing polymorphism, prion strains are encoded by alternative packing arrangements (polymorphs) of beta-sheets formed by the same segment of a protein; in segmental polymorphism, prion strains are encoded by distinct beta-sheets built from different segments of a protein. Both forms of polymorphism can produce enduring conformations capable of encoding strains. These molecular mechanisms for transfer of protein-encoded information into prion strains share features with the familiar mechanism for transfer of nucleic acid-encoded information into microbial strains, including sequence specificity and recognition by noncovalent bonds.


Subject(s)
Amyloid/chemistry , Prions/chemistry , Amino Acid Sequence , Amyloid/ultrastructure , Animals , Crystallography, X-Ray , Humans , Islet Amyloid Polypeptide , Mice , Microscopy, Electron , Models, Molecular , Molecular Sequence Data , Protein Structure, Tertiary
5.
Protein Sci ; 18(7): 1521-30, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19475663

ABSTRACT

Islet Amyloid Polypeptide (IAPP or amylin) is a peptide hormone produced and stored in the beta-islet cells of the pancreas along with insulin. IAPP readily forms amyloid fibrils in vitro, and the deposition of fibrillar IAPP has been correlated with the pathology of type II diabetes. The mechanism of the conversion that IAPP undergoes from soluble to fibrillar forms has been unclear. By chaperoning IAPP through fusion to maltose binding protein, we find that IAPP can adopt a alpha-helical structure at residues 8-18 and 22-27 and that molecules of IAPP dimerize. Mutational analysis suggests that this dimerization is on the pathway to fibrillation. The structure suggests how IAPP may heterodimerize with insulin, which we confirmed by protein crosslinking. Taken together, these experiments suggest the helical dimerization of IAPP accelerates fibril formation and that insulin impedes fibrillation by blocking the IAPP dimerization interface.


Subject(s)
Amyloid/chemistry , Insulin/metabolism , Amino Acid Sequence , Amyloid/genetics , Amyloid/metabolism , Binding Sites , Carrier Proteins/chemistry , Carrier Proteins/genetics , Carrier Proteins/metabolism , Crystallography, X-Ray , Diabetes Mellitus, Type 2/metabolism , Humans , Insulin/chemistry , Islet Amyloid Polypeptide , Maltose-Binding Proteins , Models, Molecular , Molecular Sequence Data , Mutation , Protein Binding , Protein Multimerization , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
6.
Protein Sci ; 17(9): 1467-74, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18556473

ABSTRACT

Human islet amyloid polypeptide (IAPP or amylin) is a 37-residue hormone found as fibrillar deposits in pancreatic extracts of nearly all type II diabetics. Although the cellular toxicity of IAPP has been established, the structure of the fibrillar form found in these deposits is unknown. Here we have crystallized two segments from IAPP, which themselves form amyloid-like fibrils. The atomic structures of these two segments, NNFGAIL and SSTNVG, were determined, and form the basis of a model for the most commonly observed, full-length IAPP polymorph.


Subject(s)
Amyloid/chemistry , Islets of Langerhans/chemistry , Amino Acid Sequence , Amyloid/genetics , Amyloid/isolation & purification , Amyloid/metabolism , Amyloid/ultrastructure , Carrier Proteins/chemistry , Carrier Proteins/metabolism , Computer Simulation , Crystallization , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Disulfides/chemistry , Histidine/metabolism , Humans , Hydrogen Bonding , Islet Amyloid Polypeptide , Maltose-Binding Proteins , Models, Molecular , Molecular Sequence Data , Mutation , Protein Conformation , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid , Solubility , X-Ray Diffraction
7.
Nature ; 447(7143): 453-7, 2007 May 24.
Article in English | MEDLINE | ID: mdl-17468747

ABSTRACT

Amyloid fibrils formed from different proteins, each associated with a particular disease, contain a common cross-beta spine. The atomic architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by X-ray microcrystallography. It is a pair of beta-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'. Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both. These include segments from the Alzheimer's amyloid-beta and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide (IAPP), lysozyme, myoglobin, alpha-synuclein and beta(2)-microglobulin, suggesting that common structural features are shared by amyloid diseases at the molecular level. Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of atomic architectures for amyloid-like fibrils and offer an atomic-level hypothesis for the basis of prion strains.


Subject(s)
Amyloid/chemistry , Peptide Fragments/chemistry , Amino Acid Sequence , Crystallization , Models, Molecular , Prions/chemistry , Protein Conformation
8.
Nat Struct Mol Biol ; 12(5): 403-7, 2005 May.
Article in English | MEDLINE | ID: mdl-15852023

ABSTRACT

The Mre11 complex (in Saccharomyces cerevisiae: Mre11, Rad50 and Xrs2) influences multiple facets of chromosome break metabolism. A conserved feature of the Mre11 complex is a zinc-coordinating motif in Rad50 called the Rad50 hook. We established a diploid yeast strain, rad50(hook), in which Rad50 is encoded in halves, one from each of the two RAD50 alleles, with the residues constituting the hook deleted. In all respects, rad50(hook) phenocopies complete Rad50 deficiency. Replacing the hook domain with a ligand-inducible FKBP dimerization cassette partially mitigated all phenotypes in a ligand-dependent manner. The data indicate that the Rad50 hook is critical for Mre11 complex-dependent DNA repair, telomere maintenance and meiotic double-strand break formation. Sister chromatid cohesion was unaffected by Rad50 deficiency, suggesting that molecular bridging required for recombinational DNA repair is qualitatively distinct from cohesin-mediated sister chromatid cohesion.


Subject(s)
DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Endodeoxyribonucleases/metabolism , Exodeoxyribonucleases/metabolism , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Cell Division , DNA, Fungal/genetics , DNA, Fungal/metabolism , DNA-Binding Proteins/genetics , Ligands , Meiosis/genetics , Mutation/genetics , Phenotype , Protein Binding , Protein Structure, Tertiary , Recombination, Genetic/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Telomere/metabolism
9.
Cancer Cell ; 7(4): 301-11, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15837620

ABSTRACT

Recent structural studies of epidermal growth factor receptor (EGFR) family extracellular regions have identified an unexpected mechanism for ligand-induced receptor dimerization that has important implications for activation and inhibition of these receptors. Here we describe the 2.8 angstroms resolution X-ray crystal structure of the antigen binding (Fab) fragment from cetuximab (Erbitux), an inhibitory anti-EGFR antibody, in complex with the soluble extracellular region of EGFR (sEGFR). The sEGFR is in the characteristic "autoinhibited" or "tethered" inactive configuration. Cetuximab interacts exclusively with domain III of sEGFR, partially occluding the ligand binding region on this domain and sterically preventing the receptor from adopting the extended conformation required for dimerization. We suggest that both these effects contribute to potent inhibition of EGFR activation.


Subject(s)
Antibodies, Monoclonal/chemistry , ErbB Receptors/chemistry , Models, Molecular , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal, Humanized , Antigen-Antibody Complex/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/immunology , Binding Sites/genetics , Binding, Competitive , Cetuximab , Crystallography, X-Ray , Epidermal Growth Factor/chemistry , Epitopes/chemistry , Epitopes/genetics , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/immunology , Humans , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/immunology , Immunoglobulin Fab Fragments/pharmacology , Mutation/genetics , Protein Binding , Protein Structure, Quaternary , Protein Structure, Tertiary/drug effects , Receptor Aggregation/drug effects , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Transforming Growth Factor alpha/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...